Literature DB >> 22644264

Significantly higher procalcitonin levels could differentiate Gram-negative sepsis from Gram-positive and fungal sepsis.

Helena Brodská1, Karin Malíčková, Václava Adámková, Hana Benáková, Markéta Marková Šťastná, Tomáš Zima.   

Abstract

Procalcitonin (PCT) levels can distinguish between infectious and non-infectious systemic inflammatory response. However, there are some differences between Gram-negative (G-), Gram-positive (G+), and fungal bloodstream infections, particularly in different cytokine profiles, severity and mortality. The aim of current study was to examine whether PCT levels can serve as a distinguishing mark between G+, G-, and fungal sepsis as well. One hundred and sixty-six septic patients with positive blood cultures were examined on C-reactive protein (CRP) and PCT on the same date of blood culture evaluation. The median (interquartile range, IQR) of CRP and PCT in G+, G-, and fungal cohorts and comparison of measured values between groups were made using the Kruskal-Wallis test with subsequent Bonferroni's corrections, with p < 0.05. In 83/166 (50 %) of blood cultures, G+ microbes, 78/166 (47 %) G- rods, and 5/166 (3 %) fungi were detected. PCT concentrations (ng/ml) were significantly higher in G- compared to other cohorts: 8.90 (1.88; 32.60) in G-, 0.73 (0.22; 3.40) in G+, and 0.58 (0.35; 0.73) in fungi (p < 0.00001). CRP concentrations did not differ significantly in groups. Significantly higher PCT levels could differentiate G- sepsis from G+ and fungemia. In contrast to CRP, PCT is a good discriminative biomarker in different bloodstream infections.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22644264     DOI: 10.1007/s10238-012-0191-8

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  18 in total

1.  Procalcitonin: a possible marker of invasive fungal infection in high risk patients?

Authors:  M T Montagna; C Coretti; G Caggiano
Journal:  J Prev Med Hyg       Date:  2011-03

Review 2.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Authors:  Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

3.  Biomarkers in the critically ill patient: C-reactive protein.

Authors:  Jean-Louis Vincent; Katia Donadello; Xavier Schmit
Journal:  Crit Care Clin       Date:  2011-04       Impact factor: 3.598

4.  Sepsis in European intensive care units: results of the SOAP study.

Authors:  Jean-Louis Vincent; Yasser Sakr; Charles L Sprung; V Marco Ranieri; Konrad Reinhart; Herwig Gerlach; Rui Moreno; Jean Carlet; Jean-Roger Le Gall; Didier Payen
Journal:  Crit Care Med       Date:  2006-02       Impact factor: 7.598

5.  Gram-negative bacteremia induces greater magnitude of inflammatory response than Gram-positive bacteremia.

Authors:  Ryuzo Abe; Shigeto Oda; Tomohito Sadahiro; Masataka Nakamura; Yo Hirayama; Yoshihisa Tateishi; Koichiro Shinozaki; Hiroyuki Hirasawa
Journal:  Crit Care       Date:  2010-03-04       Impact factor: 9.097

6.  Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock.

Authors:  F M Brunkhorst; K Wegscheider; Z F Forycki; R Brunkhorst
Journal:  Intensive Care Med       Date:  2000-03       Impact factor: 17.440

7.  Levels of pro-inflammatory cytokines produced from cord blood in-vitro are pathogen dependent and increased in comparison to adult controls.

Authors:  Mohamed A Mohamed; Susanne Cunningham-Rundles; Charles R Dean; Tarek A Hammad; Mirjana Nesin
Journal:  Cytokine       Date:  2007-09-19       Impact factor: 3.861

8.  Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes?

Authors:  I Delèvaux; M André; M Colombier; E Albuisson; F Meylheuc; R-J Bègue; J-C Piette; O Aumaître
Journal:  Ann Rheum Dis       Date:  2003-04       Impact factor: 19.103

9.  Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either Gram negative or Gram positive bacteria.

Authors:  Pierre Emmanuel Charles; Sylvain Ladoire; Serge Aho; Jean-Pierre Quenot; Jean-Marc Doise; Sébastien Prin; Niels-Olivier Olsson; Bernard Blettery
Journal:  BMC Infect Dis       Date:  2008-03-26       Impact factor: 3.090

Review 10.  Bench-to-bedside review: sepsis, severe sepsis and septic shock - does the nature of the infecting organism matter?

Authors:  Hongmei Gao; Timothy W Evans; Simon J Finney
Journal:  Crit Care       Date:  2008-05-06       Impact factor: 9.097

View more
  40 in total

1.  Comparison of serum procalcitonin in respiratory infections and bloodstream infections.

Authors:  Yanhui Zhu; Yulin Yuan; Huayi Huang
Journal:  Int J Clin Exp Med       Date:  2015-11-15

2.  Analysis of peritoneal galactomannan for the diagnosis of Aspergillus peritonitis.

Authors:  Karl Dichtl; Johannes Wagener; Johannes Tschöp; Ludwig Ney
Journal:  Infection       Date:  2016-05-09       Impact factor: 3.553

Review 3.  Procalcitonin-guided antibiotic treatment in critically ill patients.

Authors:  Andreas Hohn; Bernhard Heising; Jan-Karl Schütte; Olaf Schroeder; Stefan Schröder
Journal:  Langenbecks Arch Surg       Date:  2016-06-10       Impact factor: 3.445

4.  IL-8 gene locus is associated with risk, severity and 28-day mortality of sepsis in a Chinese population.

Authors:  Peng Fu; Shouxiang Xie; Xiangcheng Zhang
Journal:  Clin Exp Med       Date:  2019-10-09       Impact factor: 3.984

5.  Usefulness of procalcitonin in differentiating Candida and bacterial blood stream infections in critically ill septic patients outside the intensive care unit.

Authors:  Filippo Pieralli; Lorenzo Corbo; Arianna Torrigiani; Dario Mannini; Elisa Antonielli; Antonio Mancini; Francesco Corradi; Fabio Arena; Alberto Moggi Pignone; Alessandro Morettini; Carlo Nozzoli; Gian Maria Rossolini
Journal:  Intern Emerg Med       Date:  2017-02-04       Impact factor: 3.397

6.  DNA methylation pattern of CALCA in preterm neonates with bacterial sepsis as a putative epigenetic biomarker.

Authors:  Kristina A Tendl; Stefan M F Schulz; Thomas P Mechtler; Adele Bohn; Thomas Metz; Susanne Greber-Platzer; David C Kasper; Kurt R Herkner; Chike B Item
Journal:  Epigenetics       Date:  2013-10-17       Impact factor: 4.528

7.  Ability of serum procalcitonin to distinguish focus of infection and pathogen types in patients with bloodstream infection.

Authors:  Yinzhi Leng; Caiyun Chen; Yongxiang Zhang; Can Luo; Bo Liu
Journal:  Ann Transl Med       Date:  2019-04

8.  CRP/albumin ratio: A promising marker of gram-negative bacteremia in late-onset neonatal sepsis.

Authors:  Hatice Güneş; Sadık Yurttutan; Mustafa Çobanuşağı; Adem Doğaner
Journal:  Turk Arch Pediatr       Date:  2021-01-01

9.  Diagnostic Accuracy of Procalcitonin for Differentiating Bacteraemic Gram-Negative Sepsis from Gram-Positive Sepsis.

Authors:  Beliz Bilgili; Murat Haliloğlu; Melek Süzer Aslan; İsmet Sayan; Umut Sabri Kasapoğlu; İsmail Cinel
Journal:  Turk J Anaesthesiol Reanim       Date:  2018-02-01

10.  Evaluation of vitreous Procalcitonin as a diagnostic biomarker in infectious endophthalmitis.

Authors:  Poonam Naik; Gagan Satyashree; Ashik Mohamed; Taraprasad Das; Vivek Pravin Dave; Joveeta Joseph
Journal:  Int Ophthalmol       Date:  2021-05-24       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.